GW-274150

DB12237InvestigationalSmall molecule

GW274150 has been used in trials studying the treatment and prevention of Asthma, Migraine, Migraine Disorders, and Arthritis, Rheumatoid.

Chemical structure of GW-274150
Mechanism
Curator reviewed
Formula / weight
C8H17N3O2S · 219.3 g/mol (avg)
Code names
GW-274150

Resolves to

Compound
UNII0ZZF1V8G63CAS210354-22-6ChEMBLCHEMBL114551PubChem9797017
Structure
InChIKeyMOLOJNHYNHBPCW-ZETCQYMHSA-NSMILESCC(=N)NCCSCC[C@H](N)C(O)=O
Targets
P35228NOS2

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with GW-274150, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In